Novel Digital Architecture of a "Low Carb Program" for Initiating and Maintaining Long-Term Sustainable Health-Promoting Behavior Change in Patients with Type 2 Diabetes

JMIR Diabetes
Charlotte Summers, Kristina Curtis

Abstract

Globally, the burden of noncommunicable diseases such as type 2 diabetes is crippling health care systems. Type 2 diabetes, a disease linked with obesity, affects 1 in every 30 people today and is expected to affect 1 in 10 people by 2030. Current provisions are struggling to manage the trajectory of type 2 diabetes prevalence. Offline, face-to-face education for patients with type 2 diabetes has shown to lack long-term impact or the capacity for widespread democratized adoption. Digitally delivered interventions have been developed for patients with type 2 diabetes, and the evidence shows that some interventions provide the capacity to support hyperpersonalization and real-time continuous support to patients, which can result in significant engagement and health outcomes. However, digital health app engagement is notoriously difficult to achieve. This paper reviews the digital behavior change architecture of the Low Carb Program and the application of health behavioral theory underpinning its development and use in scaling novel methods of engaging the population with type 2 diabetes and supporting long-term behavior change.

References

Jan 1, 1978·The American Journal of Clinical Hypnosis·S De Shazer
Feb 1, 1991·Journal of Consulting and Clinical Psychology·R R WingA Jawad
May 1, 1995·Health Education Quarterly·V J StrecherD W Bulger
Jan 1, 1994·American Journal of Public Health·C S SkinnerH Hospers
Jan 1, 1996·Stroke; a Journal of Cerebral Circulation·S LehtoM Laakso
May 1, 1996·Preventive Medicine·J BrugH de Vries
May 6, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·Y GroeneveldM P Springer
Aug 10, 1999·Diabetes/metabolism Research and Reviews·R R Rubin, M Peyrot
Mar 18, 2000·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·M W KreuterB Glassman
Feb 24, 2001·Annals of Internal Medicine·V J StevensUNKNOWN Trials for the Hypertension Prevention Research Group
Jul 26, 2002·Journal of Behavioral Medicine·Abigail L Wroe
Aug 20, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·R M VinerS Hey
Sep 17, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·R PadwalD C W Lau
Dec 16, 2003·American Journal of Health Behavior·Matthew W Kreuter, Ricardo J Wray
Jul 9, 2004·The Annals of Pharmacotherapy·Kimberley KrapekTeresa J Lubowski
Aug 7, 2004·British Journal of Health Psychology·Marie ClarkRobert Simpson
Jan 19, 2005·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·K Elfhag, S Rössner
Apr 23, 2005·The Cochrane Database of Systematic Reviews·T DeakinR D R R Williams
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Apr 6, 2006·Journal of Nutrition Education and Behavior·Johannes BrugBas Verplanken
May 17, 2006·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Willemieke KroezeJohannes Brug
Sep 27, 2006·Archives of Internal Medicine·P Michael HoDavid J Magid
Nov 23, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·V L FranklinS A Greene
Mar 16, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J KarlssonM Sullivan
Sep 21, 2007·The New England Journal of Medicine·Steven A Schroeder
May 24, 2008·Disease Management : DM·David B LawrenceMichael Demand
Jan 15, 2009·Journal of Medical Internet Research·Kevin PatrickGregory J Norman
May 28, 2010·Family Practice·Jose F Caro, Edwin B Fisher

❮ Previous
Next ❯

Citations

Apr 26, 2020·Journal of Behavioral Medicine·Lisa A Eaton, Seth C Kalichman
Nov 24, 2020·Diabetes Research and Clinical Practice·Esmaeil MehraeenVahideh Aghamohammadi
Jul 30, 2021·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·Adrian BrownDuane Mellor
Sep 2, 2021·Current Opinion in Endocrinology, Diabetes, and Obesity·Peter J Foley

❮ Previous
Next ❯

Software Mentioned

COM
iOS

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.